Difficulty: Medium
Average Score: 85%
Practice
A 27-year-old man presents to the urgent care clinic with multiple painful ulcers on the shaft of his penis. Some strains of the causative virus are resistant because of a mutated thymidine kinase enzyme. Which of the following antivirals may be less effective in treating this man's infection if his strain of virus has a mutated thymidine kinase?
Correct answer
A
Rationale
In this scenario, the correct answer is A) Acyclovir. Acyclovir is a nucleoside analog antiviral drug that requires activation by viral thymidine kinase to become active against herpes simplex virus (HSV) infections. If the virus has a mutated thymidine kinase enzyme, it may not be able to activate acyclovir effectively, leading to reduced efficacy of the drug in treating the infection.
Option B) Cidofovir does not require viral thymidine kinase activation for its antiviral activity, so it would still be effective against the virus with a mutated thymidine kinase.
Option C) Foscarnet is a pyrophosphate analog that directly inhibits viral DNA polymerase and does not require activation by thymidine kinase. Therefore, it would remain effective against the virus with a mutated thymidine kinase.
Option D) Oseltamivir is an antiviral medication used to treat influenza viruses and works by inhibiting the neuraminidase enzyme, which is not related to thymidine kinase. Therefore, the mutation in thymidine kinase would not affect the effectiveness of oseltamivir.
In an educational context, understanding the mechanisms of action of antiviral drugs and how viral mutations can impact their efficacy is crucial for healthcare providers to make informed treatment decisions. This knowledge helps in selecting the most appropriate antiviral therapy tailored to the specific characteristics of the infecting virus, ultimately improving patient outcomes.
Option B) Cidofovir does not require viral thymidine kinase activation for its antiviral activity, so it would still be effective against the virus with a mutated thymidine kinase.
Option C) Foscarnet is a pyrophosphate analog that directly inhibits viral DNA polymerase and does not require activation by thymidine kinase. Therefore, it would remain effective against the virus with a mutated thymidine kinase.
Option D) Oseltamivir is an antiviral medication used to treat influenza viruses and works by inhibiting the neuraminidase enzyme, which is not related to thymidine kinase. Therefore, the mutation in thymidine kinase would not affect the effectiveness of oseltamivir.
In an educational context, understanding the mechanisms of action of antiviral drugs and how viral mutations can impact their efficacy is crucial for healthcare providers to make informed treatment decisions. This knowledge helps in selecting the most appropriate antiviral therapy tailored to the specific characteristics of the infecting virus, ultimately improving patient outcomes.